Clinical Data Presented at ACC 2025 Shows Sensydia CPS™ Provides Accurate Assessment of Mean Pulmonary Artery Pressure Non-Invasively

Sotatercept FAERS study highlights emerging safety signals in PAH treatment

At ACC 2025, new real-world safety data were presented on sotatercept, a novel fusion protein for pulmonary arterial hypertension (PAH).The post Sotatercept FAERS study highlights emerging safety signals in PAH treatment appeared first on Clinical Trials Arena.

CorVista Health Presents New Data On Non-Invasive Point Of Care Testing For Pulmonary Capillary Wedge Pressure (PCWP) Elevation Using Machine Learning - Medical Device News Magazine

CoreVista Health advises the poster titled ‘Point-of-Care Testing for Pulmonary Capillary Wedge Pressure Elevation Using Machine Learning on Non-invasive Signals’ was presented at the American College of Cardiology’s Annual Scientific Session (ACC.25) in Chicago on March 30, 2025.

CAC Scoring Shines at ACC 2025 - The Imaging Wire

The American College of Cardiology’s annual meeting is wrapping up today in Chicago, and new research into coronary artery calcium scoring has been one of cardiac imaging’s top trends at McCormick Place. CAC scoring has been around for ages as a way to detect and quantify calcium buildup in the coronary arteries based on data from non-contrast CT scans.  But it’s only been in recent years that CAC scoring has come into its own as a tool for pre…

Clinical Data Presented at ACC 2025 Shows Sensydia CPS™ Provides Accurate Assessment of Mean Pulmonary Artery Pressure Non-Invasively

— Non-invasive platform offers potential to transform heart failure care — — CPS on display for physicians in Sensydia booth #8029 at the American College of Cardiology (ACC) Annual Scientific Session & Expo — CHICAGO–(BUSINESS WIRE)–Sensydia, a clinical-stage non-invasive cardiac assessment company, announced today that University of Minnesota investigators presented positive clinical findings from a recent study evaluating the company’s AI-po…